Health Canada bans valsartan from Chinese manufacturing unit

Health Canada, the government department responsible for national public health, in its recent announcement unveiled that it has found the manufacturing site of Chinese drug Zhejiang Huahai Pharmaceuticals to be non-compliant with the requirements of GMPs (Good Manufacturing Practices). GMPs, for the record, are international standards that help ensure that …